Measurement of health-related quality of life in multiple myeloma

British Journal of Haematology

Volumn 92, Issue 3, 1996, Pages 604-613

  Wisloff, Finn ^a   Eika, Sverre ^a   Hippe, Erik ^b   Hjorth, Martin ^c,d   Holmberg, Erik ^d   Kaasa, Stein ^e   Palva, Ilmari ^f   Westin, Jan ^g  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Lidköping Hospital   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Multiple myeloma; Quality of life; Questionnaire; Reliability; Validity

Indexed keywords

ALPHA2B INTERFERON; MELPHALAN; PREDNISONE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

EID: 0029869758     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.352889.x     Document Type: Article

References (18)

1. Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J., Filiberti, A., Flechtner, S., Fleishman, S.B., de Haes, J.C.J.M., Kaasa, S., Klee, M., Osoba, D., Razavi, D., Rofe, P.B., Schraub, S., Sneeuw, K., Sullivan, M. & Takeda, F. (1995) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365-376.
2. Bjordal, K. & Kaasa, S. (1995) Psychological distress in head and neck cancer patients 7-11 years after curative treatment. British Journal of Cancer, 71, 592-597.
3. Cella, D.F., Tulsky, D.S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S.B., Winicour, P., Brannon, J., Eckberg, K., Lloyd, S., Purl, S., Blendowski, C., Goodman, M., Barnicle, M., Stewart, I., McHale, M. Bonomi, P., Kaplan, K., Taylor, S., Thomas, C.R. & Harris, J. (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. Journal of Clinical Oncology, 11, 570-579.
4. de Haes, J.C., Raatgever, J.W., van der Burg, M.E., Hamersma, E. & Neijt, J.P. (1987) Evaluation of the quality of life of patients with advanced ovarian cancer treated with combination chemotherapy. Monograph Series of the European Organization for Research and Treatment of Cancer, 17, 215-226.
5. Donovan, K., Sanson-Fisher, R.W. & Redman, S. (1989) Measuring quality of life in cancer patients. Journal of Clinical Oncology, 7, 959-968.
6. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Cancer, 36, 842-854.
7. Gardner, M., Gardner, S.B. & Winter, P.D. (1989) Confidence Interval Analysis (CIA): Microcomputer Program Manual, pp. 7-18. British Medical Journal. London. ISBN 07297 02814.
8. Gregory, W.M., Richards, M.A. & Malpas, J.S. (1992) Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. Journal of Clinical Oncology, 10, 334-342.
9. Guyatt, G.H., Feeny, D.H. & Patrick, D.L. (1993) Measuring health-related quality of life. Annals of Internal Medicine, 118, 622-629.
10. Hays, R.D. & Hadorn, D. (1992) Responsiveness to change: an aspect of validity, not a separate dimension. Quality of life Research, 1, 73-75.
11. Hjermstad, M.J., Fosså, S.D., Bjordal, K. & Kaasa, S. (1995) Test/ retest study of the European Organization for Research and Treatment of Cancer core quality-of-life questionnaire. Journal of Clinical Oncology, 13, 1249-1254.
12. Hjorth, M., Westin, J., Dahl, I.M.S., Gimsing, P., Hippe, E., Holmberg, E., Lamvik, J., Lanng Nielsen, J., Löfvenberg, E., Palva, I.P., Rödjer, S., Talstad, I., Turesson, I., Wisloff, F. & Zador, G. (1995) Inteferon-alfa-2b in addition to melphalan-prednisone for initial and maintenance treatment in multiple myeloma: a randomized Nordic trial. Annals of Internal Medicine, in press.
13. Hopwood, P., Stephens, R.J. & Machin, D. (1994) Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council lung cancer working party palliative chemotherapy trial. Quality of Life Research, 3, 339-352.
14. Kaasa, S., Bjordal, K., Aaronson, N., Moum, T., Wist, E., Hagen, S., Kvikstad, A., and The EORTC Study Group on Quality of Life (1995) The EORTC core quality of life questionnaire, (QLQ-C30): validity and reliability when analyzed with patients treated with palliative radiotherapy. European Journal of Cancer, in press.
15. Nunnally, J.C. (1978) Psychometric Theory, 2nd edn, pp. 225-256. McGraw-Hill, New York.
16. Schipper, H., Clinch, J., McMurray, M. & Levitt, M. (1984) Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. Journal of Clinical Oncology, 2, 472-483.
17. Stalfelt, A.M. & Wadman, B. (1993) Assessing quality of life in leukemia: presentation of an instrument for assessing quality of life in patients with blood malignancies. Quality Assurance in Health Care, 5, 201-211.
18. Weeks, J. (1992) Quality-of-life assessment: performance status upstaged? (Editorial). Journal of Clinical Oncology, 10, 1827-1829.